Evidence map›Paper›PMID 19730963›Full record

ArticleClinical orthopaedics and related research2010

THA with the ABG I prosthesis at 15 years. Excellent survival with minimal osteolysis.

P N Baker, I A McMurtry, G Chuter, A Port, J Anderson

Abstract read
In one paragraph

Article in Clinical orthopaedics and related research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cementless hydroxyapatite coated hip prostheses.BioMed research international · 2015
    Article
  8. High 10-year survival rate with an anatomic cementless stem (SPS).Clinical orthopaedics and related research · 2012
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

P N BakerDepartment of Trauma and Orthopaedics, James Cook University Hospital, Ward 36, Middlesbrough, Teesside TS4 3BW, UK. drpnbaker@hotmail.com
I A McMurtry
G Chuter
A Port
J Anderson
James Cook University Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledFollowing recent reports of poor results with the hydroxyapatite-coated ABG I prosthesis, we report the survival of a series of 63 patients (69 hips) at a mean of 15 years (range, 13-17 years). In total, eight patients had revision procedures. The reason for revision was acetabular loosening in all cases. In only one case was there associated clinical and radiographic loosening of the femoral stem. The 15-year survival of the acetabular component was 86.9% (95% confidence interval, 71.7%-96.0%) and the 15-year survival of the femoral component was 98.6% (95% confidence interval, 88.8%-100.0%). Periacetabular osteolysis was seen in 10 of 59 (17%) surviving hips. In these hips the components remained well fixed owing to the remaining bone-component contact. There was no difference in the Oxford hip score between patients with well-fixed hips and evidence of osteolysis and patients with hips without evidence of osteolysis. Multivariate analysis failed to reveal any factors associated with the presence of osteolysis (gender, age at primary surgery, Oxford hip score, cup abduction, and acetabular polyethylene wear rates). The ABG I prosthesis continues to show excellent long-term results. Ongoing radiographic review is recommended to detect progressive osteolysis that otherwise remains clinically silent until failure. LEVEL OF EVIDENCE: Level IV, Case series. See Guidelines for Authors for a complete description of levels of evidence.

Indexed as

Hip ProsthesisPostoperative ComplicationsAdultAgedArthroplasty, Replacement, HipCoated Materials, BiocompatibleDurapatiteEquipment FailureFemaleFollow-Up StudiesHumansMaleMiddle AgedOsteolysisProsthesis DesignProsthesis FailureCoated Materials, BiocompatibleDurapatite

Identifiers

PMID19730963
PMCPMC2882022
OpenAlexW2038890275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.